Samuel Pinson IV

“Health care constantly evolves—whether through new technologies, changing regulatory expectations, or transactions reshaping health care delivery. I help health care organizations navigate that complexity and make decisions today that remain sound as their businesses grow.” —Samuel Pinson IV

Attorney Samuel Pinson advises digital health companies, health systems, provider organizations, and investors on health care regulatory and transactional matters.

Sam works with startups, established companies, and institutional organizations across the health care landscape in the United States and abroad. He helps clients evaluate regulatory challenges, structure commercial relationships, support health care transactions, and assess the requirements associated with entering new markets. His approach takes into account both legal requirements and clients’ practical business needs.

Sam counsels clients on regulatory frameworks and business structures pertaining to health care and data innovation, including fraud and abuse laws (the Anti-Kickback Statute and the Stark Law); corporate practice of medicine restrictions; state and federal privacy and AI laws; U.S. Food and Drug Administration requirements for software as a medical device; and fee-for-service and value-based reimbursement programs.

He also assists clients in evaluating legal and policy considerations associated with generative AI applications, autonomous technologies, and diagnostic tools.

Sam’s involvement in health care AI and innovation policy extends beyond his client work. He leads a state AI policy work group for the American Telemedicine Association’s AI in Virtual Care Policy Initiative and participates in the Coalition for Health AI’s legal, direct-to-consumer, and policy work groups. He also mentors health care innovation and medical technology companies through a global innovation platform’s accelerator programs in Arkansas, Florida, and Indiana. Sam holds the Artificial Intelligence Governance Professional (AIGP) certification. These activities provide him with additional perspective on the developing legal and policy environment for AI in health care.

Before joining Epstein Becker Green, Sam practiced at a boutique digital health law firm, where he worked on corporate, regulatory, and health care innovation matters. During law school, he interned with national organizations across several sectors, including a private-equity-backed health care group practice. Outside the office, Sam enjoys spending time with family, trying new restaurants, and cooking and golfing (with mixed success).

What Sam Delivers for Clients

• Health Care M&A That Keeps Transactions Moving: Sam supports health care companies, investors, and strategic acquirers in connection with mergers, acquisitions, and other transactions. His work includes regulatory diligence, issue identification, and assistance in developing practical approaches to potential risks.
• Commercial Agreements That Move at Start-Up Speed: Lengthy contract cycles can delay the launch and growth of health care companies. Sam structures and negotiates an array of commercial contracts, helping companies protect their interests while keeping deals moving at the pace their growth demands.
• Coordinated Guidance Across Regulatory Regimes: Health systems operate across overlapping fraud and abuse, reimbursement, licensure, privacy, and corporate regulatory frameworks. Sam helps health systems and other institutional providers understand how these requirements interact when structuring transactions, developing new service lines, entering commercial arrangements, and adapting care delivery models, helping clients address regulatory risk without losing sight of operational and strategic objectives.
• Corporate Structuring Built for What Comes Next: Health innovation companies need corporate structuring and contracting support that can accommodate increasingly complex transactions. Sam works with clients on early-stage financings and strategic business transactions, putting agreements and structures in place with their future business needs in mind.
• Reimbursement Strategy for Business Models Still Being Defined: Emerging care models, including concierge medicine arrangements, can raise complex reimbursement and structuring questions. Sam helps clients evaluate corporate, fee-for-service, and value-based reimbursement considerations as they develop and refine their business models.

Mergers, Acquisitions, and Financing Due Diligence

• Conducted due diligence in connection with various M&A transactions and financings involving telehealth and virtual care companies ranging from $3 million to in excess of $50 million.

• International Association of Privacy Professionals, Artificial Intelligence Governance Professional (AIGP)

Education

• University of Miami School of Law (J.D., 2023)
  • Editorial Board Member, University of Miami International and Comparative Law Review
  • Transactional Law Concentration
  • Transactional Skills and Drafting Program; Introduction to the Deal Practicum
  • CALI Award, International Finance
• University of Central Florida (B.A., 2020)

Professional & Community Involvement

• American Telemedicine Association:
  • AI in Virtual Care Policy Initiative, State AI Policy Work Group Lead
  • Food as Medicine Coalition, Work Group Member
• Coalition for Health AI (CHAI), Legal, Direct-to-Consumer, and Policy Work Groups
• Plug and Play Tech Center, Mentor, Health Care Innovation and MedTech Accelerators (Arkansas, Florida, and Indiana)